Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-PS23-002, Enhancing Telehealth Strategies To Support Retention and Adherence to Antiretroviral Therapy (ART) and RFA-PS23-005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-Traditional Settings: Emergency Department; Amended Notice of Closed Meeting, 14370 [2023-04698]

Download as PDF 14370 Federal Register / Vol. 88, No. 45 / Wednesday, March 8, 2023 / Notices Comments will be used in the formulation of the final real property management business standards. FOR FURTHER INFORMATION CONTACT: Krystal J. Brumfield, Associate Administrator, Office of Government-wide Policy, General Services Administration. [FR Doc. 2023–04679 Filed 3–7–23; 8:45 am] BILLING CODE 6820–14–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention lotter on DSK11XQN23PROD with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–PS23– 002, Enhancing Telehealth Strategies To Support Retention and Adherence to Antiretroviral Therapy (ART) and RFA–PS23–005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-Traditional Settings: Emergency Department; Amended Notice of Closed Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– PS23–002, Enhancing Telehealth Strategies to Support Retention and Adherence to Antiretroviral Therapy (ART) and RFA–PS23–005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: Emergency Department, May 24–25, 2023, 10 a.m.–5 p.m., EDT, Teleconference, Centers for Disease Control and Prevention, Room 1077, 8 Corporate Blvd., Atlanta, GA 30329, in the original FRN. The meeting was published in the Federal Register on February 13, 2023, Volume 88, Number 29, page/s/ 9290. The meeting is being amended to remove RFA–PS23–005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: Emergency Department and replace with RFA–PS23–003, Exploring Preferences for Long-Acting Antiretroviral Therapies (LA–ART) in a Community-Based Sample of Priority Populations Living with HIV Who are Disproportionately Affected and the date the teleconference is has changed and should read as follows: Date: May 11–12, 2023. Time: 10 a.m.–5 p.m. (EDT). Place: Teleconference, Centers for Disease Control and Prevention, Room 1077, 8 Corporate Blvd., Atlanta, GA 30329. The meeting is closed to the public. VerDate Sep<11>2014 16:48 Mar 07, 2023 Jkt 259001 Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329, Telephone: (404) 718– 8833; Email: GAnderson@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–04698 Filed 3–7–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The CDC announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board). This meeting is open to the public, limited only by the space available and without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcomed to listen to the meeting by joining the audio conference (information below). The audio conference line has 150 ports for callers. DATES: The meeting will be held on April 19, 2023, from 1 p.m. to 4 p.m., EDT and on April 20, 2023, from 1 p.m. to 4 p.m., EDT. Written comments must be received on or before April 12, 2023. ADDRESSES: You may submit comments by mail to: Rashaun Roberts, National Institute for Occupational Safety and Health (NIOSH), CDC, 1090 Tusculum SUMMARY: PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Avenue, Mailstop C–24, Cincinnati, Ohio 45226. Meeting Information: The USA tollfree dial-in numbers are: +1 669 254 5252 US (San Jose); +1 646 828 7666 US (New York). The Meeting ID is: 161 420 2917 and the Passcode is: 23289352; Web conference by Zoom meeting connection: https://cdc.zoomgov.com/j/ 1614202917?pwd=UjhiSmpMd2RzS2kx TXRmUDUzNU1BQT09. FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226, Telephone (513) 533–6800, Toll Free 1(800) CDC– INFO, Email ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The Advisory Board’s charter was issued on August 3, 2001, renewed at appropriate intervals, and rechartered under Executive Order 13889 on March 22, 2022, and will terminate on March 22, 2024. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their E:\FR\FM\08MRN1.SGM 08MRN1

Agencies

[Federal Register Volume 88, Number 45 (Wednesday, March 8, 2023)]
[Notices]
[Page 14370]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04698]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-PS23-002, Enhancing Telehealth Strategies To 
Support Retention and Adherence to Antiretroviral Therapy (ART) and 
RFA-PS23-005, Expanding Rapid Initiation of Antiretroviral Therapy in 
Non-Traditional Settings: Emergency Department; Amended Notice of 
Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-PS23-002, Enhancing Telehealth Strategies to Support 
Retention and Adherence to Antiretroviral Therapy (ART) and RFA-PS23-
005, Expanding Rapid Initiation of Antiretroviral Therapy in Non-
traditional Settings: Emergency Department, May 24-25, 2023, 10 a.m.-5 
p.m., EDT, Teleconference, Centers for Disease Control and Prevention, 
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329, in the original FRN. 
The meeting was published in the Federal Register on February 13, 2023, 
Volume 88, Number 29, page/s/ 9290.
    The meeting is being amended to remove RFA-PS23-005, Expanding 
Rapid Initiation of Antiretroviral Therapy in Non-traditional Settings: 
Emergency Department and replace with RFA-PS23-003, Exploring 
Preferences for Long-Acting Antiretroviral Therapies (LA-ART) in a 
Community-Based Sample of Priority Populations Living with HIV Who are 
Disproportionately Affected and the date the teleconference is has 
changed and should read as follows:
    Date: May 11-12, 2023.
    Time: 10 a.m.-5 p.m. (EDT).
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329.
    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329, Telephone: (404) 718-8833; Email: 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-04698 Filed 3-7-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.